 Merck & Co. is a global health care and pharmaceutical company that is headquartered in Kenilworth, New Jersey in the U.S. The company operates globally. In 2018, the company had a total of around 69 thousand full-time employees. The number of employees at the company has been on the decline since 2009 when the company experienced their largest number of employees. At that time Merck & Co. had around 100 thousand employees globally. Merck & Co. company profile Today the company works in a variety of fields and within the scope of various illnesses. They have segments in animal health, human health and vaccines. Merck & Co.’s global revenues have been variable in recent years, but as of 2018 data indicates that revenue figures are increasing for the company. Despite a recent growth in revenues for the company, Merck & Co.’s total assets have been on the decline for the past 10 years. Despite the fluctuations in the company’s financial data, Merck & Co. remains a top competitor in the pharmaceutical industry. Products by Merck & Co. As of 2017, Merck & Co. held the second largest share of the global vaccine market. Other top companies in that year included GlaxoSmithKline, Sanofi and Pfizer. Merck & Co. continues to be among the top pharmaceutical companies, especially through the sales of their cancer drugs. In 2018 Merck & Co.’s top selling pharmaceutical product was Keytruda, an immunotherapy used to treat certain cancers. In that same year, Keytruda was among the top five global pharmaceutical products based on the number of sales. 